US 12391734
PD-1 homing endonuclease variants, compositions, and methods of use
granted A61KA61K38/00A61K40/11
Quick answer
US patent 12391734 (PD-1 homing endonuclease variants, compositions, and methods of use) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Aug 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K38/00, A61K40/11, A61K40/31, A61K40/36